Table II.

FDA method on DCE-MRI images, Ktrans and AUC maps.

		Predicted
Imaging	Type	Malignant	Benign	Discriminant accuracy (%)	Discriminant accuracy (%)
DCE-MR images	Malignant	21	2	91	93
	Benign	2	31	94
Ktrans maps	Malignant	23	0	100	98
	Benign	1	32	97
AUC maps	Malignant	23	0	100	98
	Benign	1	32	97

FDA, Fisher discriminant analysis; DCE-MRI, dynamic contrast enhanced magnetic resonance imaging; AUC area under the curve.